Focus Partners Wealth
TXG icon

Focus Partners Wealth’s 10x Genomics TXG Stock Holding History

Focus Partners Wealth’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.83M Buy
224,496
+35,437
+19% +$708K 0.01% 944
2025
Q4 		$3.08M Buy
189,059
+145,536
+334% +$2.2M ﹤0.01% 1147
2025
Q3 		$589K Buy
43,523
+13,954
+47% +$182K ﹤0.01% 1548
2025
Q2 		$342K Buy
29,569
+18,991
+180% +$173K ﹤0.01% 1611
2025
Q1 		$92.3K Buy
+10,578
New +$133K ﹤0.01% 1818

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Focus Partners Wealth's TXG Position: Q1 2026 in Review

Focus Partners Wealth increased its 10x Genomics (TXG) stake by 19% in Q1 2026, buying an estimated $708K and bringing the position to 224,496 shares worth $4.83M. The position accounts for 0.01% of the portfolio, ranked #944.

Focus Partners Wealth first reported a position in TXG in Q1 2025 and has held it in 5 quarters since. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Focus Partners Wealth held 224,496 shares of 10x Genomics worth $4.83M as of Q1 2026.
  • Focus Partners Wealth bought 35,437 10x Genomics shares in Q1 2026, an estimated $708K.
  • 10x Genomics made up 0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #944 holding.
  • Focus Partners Wealth first reported a position in 10x Genomics in Q1 2025 and has held it in 5 quarters since.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.